Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Current share price (P) | |
No. shares of common stock outstanding | |
US$ in millions | |
Common equity (market value)1 | |
Add: Preferred stock, $100 par value; none issued (per books) | |
Add: Noncontrolling interests (per books) | |
Total equity | |
Add: Short-term obligations and current maturities of long-term obligations (per books) | |
Add: Long-term obligations, excluding current maturities (per books) | |
Total equity and debt | |
Less: Cash and cash equivalents | |
Less: Short-term investments | |
Enterprise value (EV) |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Thermo Fisher Scientific Inc. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
- Common equity (market value)
- The common equity market value experienced a steady increase from 177,786 million USD in 2020 to a peak of 213,722 million USD in 2023, representing a consistent growth trend over four years. However, in 2024, there was a decline to 202,902 million USD, indicating a decrease in market valuation during the most recent period analyzed.
- Total equity
- Total equity followed a pattern very similar to common equity, rising from 177,796 million USD in 2020 to a maximum of 213,711 million USD in 2023. In 2024, total equity decreased to 202,869 million USD, mirroring the decline seen in common equity. This parallel movement suggests that total equity changes are largely driven by changes in common equity market value.
- Total equity and debt
- Total equity and debt showed a significant increase from 199,531 million USD in 2020 to a peak of 248,628 million USD in 2023. This indicates an expansion in the company’s combined financing through both equity and debt over this period. However, in 2024, this figure decreased notably to 234,144 million USD, suggesting a reduction in either debt, equity, or both components.
- Enterprise value (EV)
- The enterprise value rose markedly from 189,206 million USD in 2020 to 241,765 million USD in 2021, demonstrating a strong increase in the company’s total valuation. It experienced a slight decrease to 238,371 million USD in 2022, followed by a modest recovery to 240,548 million USD in 2023. In 2024, enterprise value declined to 228,574 million USD, indicating a reduction in the overall market valuation after several years of growth and stabilization.